ASP Isotopes Inc. is an advanced materials company specializing in isotope enrichment technology for high-value applications across medical, semiconductor, and green energy sectors. The company employs two proprietary technologies to enrich isotopes: the Aerodynamic Separation Process, which uses gaseous diffusion with a stationary wall centrifuge and proprietary flow directors, and Quantum Enrichment, which utilizes precisely tuned lasers and quantum mechanical principles to achieve selective isotope separation. ASP Isotopes operates through three business verticals: enrichment of stable isotopes for medical and semiconductor industries, nuclear medicine services through its majority stake in PET Labs in South Africa and sub-Saharan Africa acquired in 2023, and development of nuclear fuels for the future including HALEU and other critical materials through its Quantum Leap Energy subsidiaries. The company leverages over 20 years of research and development history to position itself as a supplier to multi-billion-dollar end markets in nuclear medicine, quantum computing, and green energy generation. Headquartered in Washington, DC, ASP Isotopes Inc. focuses on providing modular, cost-effective, and environmentally friendly processes for isotope production and enrichment.